Glaxosmithkline Consumer Nigeria Plc manufactures and markets a range of consumer healthcare and pharmaceutical products in Nigeria. Its product portfolio includes treatments for asthma, HIV/AIDS, malaria, depression, migraines, diabetes, heart failure, digestive ailments and cancer. Consumer healthcare products include oral healthcare products; wellness products for the management of pain, gastro-intestinal and respiratory conditions; multivitamins; and a range of nutritional healthcare beverages. Glaxosmithkline Consumer Nigeria Plc produces a range of antibacterial products and vaccines to protect against illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza and cervical cancer. The company was formerly known as Beecham Limited. Its head office is in Lagos, Nigeria.

Glaxosmithkline Consumer Nigeria Plc is listed on the Nigerian Stock Exchange

News & Corporate Announcements

Glaxosmithkline Consumer Nigeria Plc ( Share Chart

Trading Update


SalesNGN 6.00
ValueNGN 1,073,196.00
Market capNGN 7,175,258,928
Shares issued1,195,876,488


Today0.00 / 0.00%
52 week highNGN 12.00
52 week lowNGN 5.25
52 week change-50.00%
Year to date-1.64%

Market Info

Listed01st July, 1979
Year endDecember
IndexNigeria Pension Index (